Want to see ALB full AI Analyst Report?
ALB Stock Chart & Stats
$133.18
-$0.02(-0.02%)
At close: 4:00 PM EDT
$133.18
-$0.02(-0.02%)
Day’s Range― - ―
52-Week Range$79.30 - $221.00
Previous CloseN/A
Volume258.61K
Average Volume (3M)2.15M
Market Cap
$13.09B
Enterprise Value$21.25K
Total Cash (Recent Filing)$1.63B
Total Debt (Recent Filing)$1.99B
Price to Earnings (P/E)231.1
Beta1.63
Next Earnings
Nov 04, 2026EPS Estimate
2.56Next Dividend Ex-DateN/A
Dividend Yield1.47%
Share Statistics
EPS (TTM)0.48
Shares Outstanding118,005,060
10 Day Avg. Volume2,452,714
30 Day Avg. Volume2,150,141
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.75
Price to Sales (P/S)3.24
P/FCF Ratio24.04
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$176.85Price Target Upside32.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)11.48
Revenue Forecast (FY)$6.12B
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation And Lower LeverageThe sharp recovery in operating and free cash flow improves Albemarle’s ability to fund operations, reduce debt and pursue growth without relying as heavily on external capital. Lower leverage adds resilience through lithium cycles and gives management greater flexibility in capital allocation.
Improving Operating Performance And Cost DisciplineThe combination of stronger revenue, substantial EBITDA expansion and recurring productivity work indicates meaningful operating leverage across the portfolio. If savings remain embedded in the cost base, they can support margins and cash generation even when lithium pricing or volumes are less favorable.
DLE Technology And Lithium Demand GrowthHigher-recovery direct lithium extraction could improve resource efficiency and expand Albemarle’s technology advantage if successfully commercialized. At the same time, rising lithium consumption, particularly from stationary storage, supports a durable demand backdrop for the company’s core products.
Bears Say
Cyclical And Inconsistent Earnings QualityThe large swings in revenue and profitability show that Albemarle remains highly exposed to lithium pricing, demand cycles and product mix. Although results have improved, margins remain well below prior highs, making earnings power less predictable and limiting confidence in sustained returns.
CGP3 Fire Delays Capacity RampThe delayed CGP3 ramp removes expected near-term capacity and contributed to lower 2026 energy storage volume guidance. This can constrain sales and operating leverage during the recovery, while the revised timeline keeps execution risk relevant over the next several quarters.
Lithium Price Volatility Pressures Realized MarginsContract timing, product mix and inventory lags can prevent Albemarle from fully capturing market price improvements and can expose margins to delayed cost effects when prices fall. This structural mismatch makes profitability sensitive to lithium market volatility even when volumes hold up.
Albemarle News
ALB FAQ
What was Albemarle’s price range in the past 12 months?
Albemarle lowest stock price was $79.30 and its highest was $221.00 in the past 12 months.
What is Albemarle’s market cap?
Albemarle’s market cap is $13.09B.
When is Albemarle’s upcoming earnings report date?
Albemarle’s upcoming earnings report date is Nov 04, 2026 which is in 45 days.
How were Albemarle’s earnings last quarter?
Albemarle released its earnings results on Aug 05, 2026. The company reported $3.75 earnings per share for the quarter, beating the consensus estimate of $3.203 by $0.547.
Is Albemarle overvalued?
According to Wall Street analysts Albemarle’s price is currently Undervalued.
Does Albemarle pay dividends?
Albemarle pays a Quarterly dividend of $0.41 which represents an annual dividend yield of 1.47%. See more information on Albemarle dividends here
What is Albemarle’s EPS estimate?
Albemarle’s EPS estimate is 2.56.
How many shares outstanding does Albemarle have?
Albemarle has 118,005,060 shares outstanding.
What happened to Albemarle’s price movement after its last earnings report?
Albemarle reported an EPS of $3.75 in its last earnings report, beating expectations of $3.203. Following the earnings report the stock price went up 5.537%.
Which hedge fund is a major shareholder of Albemarle?
Currently, no hedge funds are holding shares in ALB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Albemarle Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$176.85 (32.79% Upside)
$176.85 (32.79% Upside)
Blogger Sentiment
Bullish
ALB Sentiment 74%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 16.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
38.61%
12-Months-Change
Fundamentals
Return on Equity
1.47%
Trailing 12-Months
Asset Growth
-8.02%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Albemarle
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
ALB Company Deck
ALB Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a strong operational and financial quarter highlighted by robust top‑line growth (net sales +31%), outsized EBITDA expansion (+155%), exceptional cash generation (Q2 cash from operations $710M and $638M FCF) and meaningful cost/productivity gains. Management raised Specialties outlook, advanced DLE pilot results (>90% recoveries) and signaled disciplined capital allocation with attractive brownfield growth options. Offsetting risks include a June fire at Greenbushes (CGP3) that delayed some volume, tight industry inventories and spodumene supply constraints, supply chain impacts from Middle East disruptions (estimated $70–$90M effect), and near‑term margin sensitivity from spodumene price timing. Overall, the positive operational execution, strong cash flow and upgraded outlooks outweigh the near‑term operational and market headwinds.View all ALB earnings summariesALB Net sales Breakdown
52.70% Energy Storage
26.57% Specialties
20.73% Ketjen
ALB Stock 12 Month Forecast
Average Price Target
$176.85
▲(32.79% Upside)
Technical Analysis
Ashland
―
Eastman Chemical
―
Sociedad Quimica Y Minera SA
―
Element Solutions
―
Chemours Company
―
Ownership Overview
0.29% Insiders
27.11% Mutual Funds
23.02% Other Institutional Investors
17.00% Public Companies and Individual Investors